The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Mucosal flora in inflammatory bowel disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Amann, R. I., Binder, B. J., Olson, R. J., Chisholm, S. W., Devereux, R., & Stahl, D. A. (1990) · Applied and Environmental Microbiology · doi:10.1128/aem.56.6.1919-1925.1990 · Cited by 4,021
Manz, W., Amann, R., Ludwig, W., Wagner, M., & Schleifer, K.-H. (1992) · Systematic and Applied Microbiology · doi:10.1016/s0723-2020(11)80121-9 · Cited by 2,043
Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB
Ogura, Y., Inohara, N., Benito, A., Chen, F. F., Yamaoka, S., & Núñez, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008072200 · Cited by 1,361
Manz, W., Amann, R., Ludwig, W., Vancanneyt, M., & Schleifer, K.-H. (1996) · Microbiology · doi:10.1099/13500872-142-5-1097 · Cited by 1,175
Hampe, J., Cuthbert, A., Croucher, P. J., Mirza, M. M., Mascheretti, S., Fisher, S., Frenzel, H., King, K., Hasselmeyer, A., MacPherson, A. J., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05063-7 · Cited by 1,092
Self-citationEuropean Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
Malchow, H., Ewe, K., Brandes, J. W., Goebell, H., Ehms, H., Sommer, H., & Jesdinsky, H. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90409-8 · Cited by 933
Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease
Darfeuille-Michaud, A., Neut, C., Barnich, N., Lederman, E., Di Martino, P., Desreumaux, P., Gambiez, L., Joly, B., Cortot, A., & Colombel, J.-F. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70019-8 · Cited by 877
Rath, H. C., Herfarth, H. H., Ikeda, J. S., Grenther, W. B., Hamm, T. E., Balish, E., Taurog, J. D., Hammer, R. E., Wilson, K. H., & Sartor, R. B. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118878 · Cited by 834
Cited by
Items 101–171 of 171
Carvalho, F. A., Barnich, N., Sivignon, A., Darcha, C., Chan, C. H. F., Stanners, C. P., & Darfeuille-Michaud, A. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090741 · Cited by 318
Di Cagno, R., De Angelis, M., De Pasquale, I., Ndagijimana, M., Vernocchi, P., Ricciuti, P., Gagliardi, F., Laghi, L., Crecchio, C., Guerzoni, M. E., et al. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-219 · Cited by 317
“In particular, cell numbers of protective Bifidobacterium and Lactobacillus decreased, while harmful Bacteroides and Escherichia coli increased [15].”
BackgroundMechanisms of Disease: the hygiene hypothesis revisited
Guarner, F., Bourdet-Sicard, R., Brandtzaeg, P., Gill, H. S., McGuirk, P., van Eden, W., Versalovic, J., Weinstock, J. V., & Rook, G. A. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0471 · Cited by 315
Lapaquette, P., Glasser, A.-L., Huett, A., Xavier, R. J., & Darfeuille-Michaud, A. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01381.x · Cited by 313
Gene–environment interaction modulated by allelic heterogeneity in inflammatory diseases
Chamaillard, M., Philpott, D., Girardin, S. E., Zouali, H., Lesage, S., Chareyre, F., Bui, T. H., Giovannini, M., Zaehringer, U., Penard-Lacronique, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530276100 · Cited by 309
The intestinal microbiota and chronic disorders of the gut
DuPont, A. W., & DuPont, H. L. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.133 · Cited by 307
Kish, L., Hotte, N., Kaplan, G. G., Vincent, R., Tso, R., Gänzle, M., Rioux, K. P., Thiesen, A., Barkema, H. W., Wine, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062220 · Cited by 306
The Epidemiology and Pathogenesis of Neoplasia in the Small Intestine
Schottenfeld, D., Beebe-Dimmer, J. L., & Vigneau, F. D. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2008.10.004 · Cited by 305
Secreted enteric antimicrobial activity localises to the mucus surface layer
Meyer-Hoffert, U., Hornef, M. W., Henriques-Normark, B., Axelsson, L.-G., Midtvedt, T., Pütsep, K., & Andersson, M. (2008) · Gut · doi:10.1136/gut.2007.141481 · Cited by 304
Nitric Oxide in Inflammatory Bowel Disease
Cross, R. K., & Wilson, K. T. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200305000-00006 · Cited by 303
Role of the intestinal barrier in inflammatory bowel disease
Laukoetter, M. G., Nava, P., & Nusrat, A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.401 · Cited by 300
Ohkusa, T., Okayasu, I., Ogihara, T., Morita, K., Ogawa, M., & Sato, N. (2003) · Gut · doi:10.1136/gut.52.1.79 · Cited by 300
WRIGHT, K., ROONEY, N., FEENEY, M., TATE, J., ROBERTSON, D., WELHAM, M., & WARD, S. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.026 · Cited by 299
The host–microbe interface within the gut
Shanahan, F. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0342 · Cited by 299
Adherent-invasive Escherichia coli in inflammatory bowel disease
Rolhion, N., & Darfeuille-Michaud, A. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20176 · Cited by 298
Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease?
Ijssennagger, N., van der Meer, R., & van Mil, S. W. C. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.01.002 · Cited by 296
Wehkamp, J., Harder, J., Weichenthal, M., Mueller, O., Herrlinger, K. R., Fellermann, K., Schroeder, J. M., & Stange, E. F. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200307000-00001 · Cited by 295
Drug delivery strategies in the therapy of inflammatory bowel disease
Lautenschläger, C., Schmidt, C., Fischer, D., & Stallmach, A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.10.001 · Cited by 291
Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis
Gersemann, M., Becker, S., Kübler, I., Koslowski, M., Wang, G., Herrlinger, K. R., Griger, J., Fritz, P., Fellermann, K., Schwab, M., et al. (2009) · Differentiation · doi:10.1016/j.diff.2008.09.008 · Cited by 288
Hansen, R., Russell, R. K., Reiff, C., Louis, P., McIntosh, F., Berry, S. H., Mukhopadhya, I., Bisset, M. W., Barclay, A. R., Bishop, J., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.335 · Cited by 288
The Paneth Cell α-Defensin Deficiency of Ileal Crohn’s Disease Is Linked to Wnt/Tcf-4
Wehkamp, J., Wang, G., Kübler, I., Nuding, S., Gregorieff, A., Schnabel, A., Kays, R. J., Fellermann, K., Burk, O., Schwab, M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3109 · Cited by 286
Pierik, M., Joossens, S., Van Steen, K., Van Schuerbeek, N., Vlietinck, R., Rutgeerts, P., & Vermeire, S. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000195389.11645.ab · Cited by 281
Oliva, S., Di Nardo, G., Ferrari, F., Mallardo, S., Rossi, P., Patrizi, G., Cucchiara, S., & Stronati, L. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04939.x · Cited by 280
Dysbiosis of Gut Fungal Microbiota is Associated With Mucosal Inflammation in Crohn’s Disease
Li, Q., Wang, C., Tang, C., He, Q., Li, N., & Li, J. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000035 · Cited by 279
Adherent and Invasive Escherichia coli Is Associated with Granulomatous Colitis in Boxer Dogs
Simpson, K. W., Dogan, B., Rishniw, M., Goldstein, R. E., Klaessig, S., McDonough, P. L., German, A. J., Yates, R. M., Russell, D. G., Johnson, S. E., et al. (2006) · Infection and Immunity · doi:10.1128/iai.00067-06 · Cited by 278
Shkoda, A., Ruiz, P. A., Daniel, H., Kim, S. C., Rogler, G., Sartor, R. B., & Haller, D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.030 · Cited by 277
Lepage, P., Seksik, P., Sutren, M., de la Cochetière, M.-F., Jian, R., Marteau, P., & Doré, J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000159662.62651.06 · Cited by 270
Gastrointestinal biofilms in health and disease
Motta, J.-P., Wallace, J. L., Buret, A. G., Deraison, C., & Vergnolle, N. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00397-y · Cited by 270
Zhou, Y., & Zhi, F. (2016) · BioMed Research International · doi:10.1155/2016/5828959 · Cited by 266
Chassaing, B., Rolhion, N., Vallée, A. D., Salim, S. Y., Prorok-Hamon, M., Neut, C., Campbell, B. J., Söderholm, J. D., Hugot, J.-P., Colombel, J.-F., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44632 · Cited by 265
The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept
Van den Abbeele, P., Van de Wiele, T., Verstraete, W., & Possemiers, S. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00270.x · Cited by 264
Martinez-Medina, M., Aldeguer, X., Gonzalez-Huix, F., Acero, D., & Garcia-Gil, J. L. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235828.09305.0c · Cited by 263
Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis
Lucke, K., Miehlke, S., Jacobs, E., & Schuppler, M. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46198-0 · Cited by 262
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis
Kühbacher, T., Ott, S. J., Helwig, U., Mimura, T., Rizzello, F., Kleessen, B., Gionchetti, P., Blaut, M., Campieri, M., Fölsch, U. R., et al. (2006) · Gut · doi:10.1136/gut.2005.078303 · Cited by 257
Self-citationVan den Abbeele, P., Gérard, P., Rabot, S., Bruneau, A., El Aidy, S., Derrien, M., Kleerebezem, M., Zoetendal, E. G., Smidt, H., Verstraete, W., et al. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02533.x · Cited by 256
Jonkers, D., Penders, J., Masclee, A., & Pierik, M. (2012) · Drugs · doi:10.2165/11632710-000000000-00000 · Cited by 240
Prorok-Hamon, M., Friswell, M. K., Alswied, A., Roberts, C. L., Song, F., Flanagan, P. K., Knight, P., Codling, C., Marchesi, J. R., Winstanley, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304739 · Cited by 236
Microbiota and the gut–brain axis
Bienenstock, J., Kunze, W., & Forsythe, P. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv019 · Cited by 234
“Altered gut microbiota can also be responsible for pathophysiology in the colon.(19,20) Gut microbiota–host misadaptation (dysbiosis) has been implicated in the rising incidence of inflammatory diseases such as inflammatory bowel disease.”
BackgroundRhee, S. H., Im, E., Riegler, M., Kokkotou, E., O'Brien, M., & Pothoulakis, C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502174102 · Cited by 229
Race-dependent association of sulfidogenic bacteria with colorectal cancer
Yazici, C., Wolf, P. G., Kim, H., Cross, T.-W. L., Vermillion, K., Carroll, T., Augustus, G. J., Mutlu, E., Tussing-Humphreys, L., Braunschweig, C., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313321 · Cited by 215
Heimesaat, M. M., Fischer, A., Siegmund, B., Kupz, A., Niebergall, J., Fuchs, D., Jahn, H.-K., Freudenberg, M., Loddenkemper, C., Batra, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000662 · Cited by 213
“at inflamed tissue sites [4–6].”
Intestinal Microbes in Inflammatory Bowel Diseases
Sartor, R. B., & Mazmanian, S. K. (2012) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2012.4 · Cited by 206
Review article: probiotics and prebiotics in irritable bowel syndrome
SPILLER, R. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03750.x · Cited by 190
Kühl, A. A., Kakirman, H., Janotta, M., Dreher, S., Cremer, P., Pawlowski, N. N., Loddenkemper, C., Heimesaat, M. M., Grollich, K., Zeitz, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.073 · Cited by 187
Margolis, D. J., Fanelli, M., Hoffstad, O., & Lewis, J. D. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.303 · Cited by 177
Yu, J., Chen, Y., Fu, X., Zhou, X., Peng, Y., Shi, L., Chen, T., & Wu, Y. (2016) · International Journal of Cancer · doi:10.1002/ijc.30168 · Cited by 176
Ohkusa, T., Yoshida, T., Sato, N., Watanabe, S., Tajiri, H., & Okayasu, I. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.005801-0 · Cited by 167
Langhorst, J., Junge, A., Rueffer, A., Wehkamp, J., Foell, D., Michalsen, A., Musial, F., & Dobos, G. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.86 · Cited by 167
Sartor, R. B. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.10.036 · Cited by 164
Role of Chitotriosidase (Chitinase 1) Under Normal and Disease Conditions
Kanneganti, M. (2012) · Journal of Epithelial Biology and Pharmacology · doi:10.2174/1875044301205010001 · Cited by 151
“In fact, some potentially pathogenic bacteria in normal microflora, including AIEC and Bacteroides species, are likely to be strongly associated with the initiation of intestinal inflammation, particularly in Crohn’s disease [96-98].”
BackgroundBowel Biofilms: Tipping Points between a Healthy and Compromised Gut?
Tytgat, H. L. P., Nobrega, F. L., van der Oost, J., & de Vos, W. M. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.08.009 · Cited by 144
Choi, C. H., Jo, S. Y., Park, H. J., Chang, S. K., Byeon, J.-S., & Myung, S.-J. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318204593e · Cited by 144
Gut inflammation in chronic fatigue syndrome
Lakhan, S. E., & Kirchgessner, A. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-79 · Cited by 143
The human gut microbiome: Implications for future health care
Kinross, J. M., von Roon, A. C., Holmes, E., Darzi, A., & Nicholson, J. K. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0075-y · Cited by 137
R-spondin 3 promotes stem cell recovery and epithelial regeneration in the colon
Harnack, C., Berger, H., Antanaviciute, A., Vidal, R., Sauer, S., Simmons, A., Meyer, T. F., & Sigal, M. (2019) · Nature Communications · doi:10.1038/s41467-019-12349-5 · Cited by 137
Real-Time Analysis of Mucosal Flora in Patients with Inflammatory Bowel Disease in India
Verma, R., Verma, A. K., Ahuja, V., & Paul, J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01360-10 · Cited by 124
Duytschaever, G., Huys, G., Bekaert, M., Boulanger, L., De Boeck, K., & Vandamme, P. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05933-11 · Cited by 114
McLaughlin, S. D., Walker, A. W., Churcher, C., Clark, S. K., Tekkis, P. P., Johnson, M. W., Parkhill, J., Ciclitira, P. J., Dougan, G., Nicholls, R. J., et al. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181e3dc8b · Cited by 114
Andoh, A., Sakata, S., Koizumi, Y., Mitsuyama, K., Fujiyama, Y., & Benno, Y. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20151 · Cited by 113
MATSUMOTO, S., NAGAOKA, M., HARA, T., KIMURA-TAKAGI, I., MISTUYAMA, K., & UEYAMA, S. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02462.x · Cited by 113
The long-term health effects of neonatal microbial flora
Conroy, M. E., Shi, H. N., & Walker, W. A. (2009) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e32832b3f1d · Cited by 83
Rhee, S. H., Keates, A. C., Moyer, M. P., & Pothoulakis, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400967200 · Cited by 81
Alard, J., Peucelle, V., Boutillier, D., Breton, J., Kuylle, S., Pot, B., Holowacz, S., & Grangette, C. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0097 · Cited by 78
Seksik, P., Lepage, P., de la Cochetière, M.-F., Bourreille, A., Sutren, M., Galmiche, J.-P., Doré, J., & Marteau, P. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4654-4658.2005 · Cited by 77
“the Bacteria domain, found no intracellular bacteria in rectal biopsy specimens from IBD patients (15, 23, 27).”
BackgroundInfluentialIntestinal microflora and metabolic diseases
Serino, M., Luche, E., Chabo, C., Amar, J., & Burcelin, R. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.03.003 · Cited by 77
Park, H. J., Kim, S. A., Kang, W. S., & Kim, J. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041899 · Cited by 59
Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease
Jergens, A. E., Parvinroo, S., Kopper, J., & Wannemuehler, M. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.669913 · Cited by 63
QseC inhibition as an antivirulence approach for colitis-associated bacteria
Rooks, M. G., Veiga, P., Reeves, A. Z., Lavoie, S., Yasuda, K., Asano, Y., Yoshihara, K., Michaud, M., Wardwell-Scott, L., Gallini, C. A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612836114 · Cited by 57
Haller, D., Holt, L., Parlesak, A., Zanga, J., Bäuerlein, A., Sartor, R. B., & Jobin, C. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01874.x · Cited by 54
E. coli-mediated gut inflammation in genetically predisposed Crohn's disease patients
Barnich, N., Denizot, J., & Darfeuille-Michaud, A. (2013) · Pathologie Biologie · doi:10.1016/j.patbio.2010.01.004 · Cited by 34
Arase, S., Watanabe, Y., Setoyama, H., Nagaoka, N., Kawai, M., & Matsumoto, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160736 · Cited by 18
Metadata
- Authors
- Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening–Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., & Lochs, H.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 122
- Issue
- 1
- Pages
- 44-54
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2009706335
- Cited by
- 1,346
- References
- 30
- FWCI
- 30.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.